Original Research
6 August 2013

Mucosal Healing and Risk for Lymphoproliferative Malignancy in Celiac Disease: A Population-Based Cohort Study

Publication: Annals of Internal Medicine
Volume 159, Number 3

Abstract

Background:

Celiac disease (CD) is associated with an increased risk for lymphoproliferative malignancy (LPM). Whether this risk is affected by the results of follow-up intestinal biopsy, performed to document mucosal healing, is unknown.

Objective:

To examine the association between mucosal healing in CD and subsequent LPM.

Design:

Population-based cohort study.

Setting:

28 pathology departments in Sweden.

Patients:

7625 patients with CD who had follow-up biopsy after initial diagnosis.

Measurements:

The risk for LPM was compared with that of the general population by using expected rates. The rate of LPM in patients with persistent villous atrophy was compared with that of those with mucosal healing by using Cox regression.

Results:

Among 7625 patients with CD and follow-up biopsy, 3308 (43%) had persistent villous atrophy. The overall risk for LPM was higher than that in the general population (standardized incidence ratio [SIR], 2.81 [95% CI, 2.10 to 3.67]) and was greater among patients with persistent villous atrophy (SIR, 3.78 [CI, 2.71 to 5.12]) than among those with mucosal healing (SIR, 1.50 [CI, 0.77 to 2.62]). Persistent villous atrophy compared with mucosal healing was associated with an increased risk for LPM (hazard ratio [HR], 2.26 [CI, 1.18 to 4.34]). The risk for T-cell lymphoma was increased (HR, 3.51 [CI, 0.75 to 16.34]) but not for B-cell lymphoma (HR, 0.97 [CI, 0.21 to 4.49]).

Limitation:

No data on dietary adherence.

Conclusion:

Increased risk for LPM in CD is associated with the follow-up biopsy results, with a higher risk among patients with persistent villous atrophy. Follow-up biopsy may effectively stratify patients with CD by risk for subsequent LPM.

Primary Funding Source:

National Institutes of Health, The American-Scandinavian Foundation, Celiac Sprue Association, Örebro University Hospital, Karolinska Institutet, Swedish Society of Medicine, Swedish Research Council, and Swedish Celiac Society.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Green PH and Cellier C. Celiac disease. N Engl J Med. 2007;357:1731-43. [PMID: 17960014]
2.
Mustalahti KCatassi CReunanen AFabiani EHeier MMcMillan Set alCoeliac EU Cluster, Project Epidemiology. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587-95. [PMID: 21070098]
3.
Rubio-Tapia AKyle RAKaplan ELJohnson DRPage WErdtmann Fet al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88-93. [PMID: 19362553]
4.
Catassi CKryszak DBhatti BSturgeon CHelzlsouer KClipp SLet al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530-8. [PMID: 20868314]
5.
Elfström PGranath FEkström Smedby KMontgomery SMAskling JEkbom Aet al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst. 2011;103:436-44. [PMID: 21289299]
6.
Catassi CFabiani ECorrao GBarbato MDe Renzo ACarella AMet alItalian Working Group on Coeliac Disease and Non-Hodgkin's-Lymphoma. Risk of non-Hodgkin lymphoma in celiac disease. JAMA. 2002;287:1413-9. [PMID: 11903028]
7.
Smedby KEAkerman MHildebrand HGlimelius BEkbom A, and Askling J. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut. 2005;54:54-9. [PMID: 15591504]
8.
Askling JLinet MGridley GHalstensen TSEkström K, and Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology. 2002;123:1428-35. [PMID: 12404215]
9.
West JLogan RFSmith CJHubbard RB, and Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004;329:716-9. [PMID: 15269095]
10.
Green PHFleischauer ATBhagat GGoyal RJabri B, and Neugut AI. Risk of malignancy in patients with celiac disease. Am J Med. 2003;115:191-5. [PMID: 12935825]
11.
Gao YKristinsson SYGoldin LRBjörkholm MCaporaso NE, and Landgren O. Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology. 2009;136:91-8. [PMID: 18950631]
12.
Ciclitira PJKing AL, and Fraser JS. AGA technical review on Celiac Sprue. American Gastroenterological Association. Gastroenterology. 2001;120:1526-40. [PMID: 11313324]
13.
Lee SKLo WMemeo LRotterdam H, and Green PH. Duodenal histology in patients with celiac disease after treatment with a gluten-free diet. Gastrointest Endosc. 2003;57:187-91. [PMID: 12556782]
14.
Rubio-Tapia ARahim MWSee JALahr BDWu TT, and Murray JA. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol. 2010;105:1412-20. [PMID: 20145607]
15.
Bardella MTVelio PCesana BMPrampolini LCasella GDi Bella Cet al. Coeliac disease: a histological follow-up study. Histopathology. 2007;50:465-71. [PMID: 17448022]
16.
Lanzini ALanzarotto FVillanacci VMora ABertolazzi STurini Det al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther. 2009;29:1299-308. [PMID: 19302264]
17.
Ciacci CCirillo MCavallaro R, and Mazzacca G. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion. 2002;66:178-85. [PMID: 12481164]
18.
Collin PMäki M, and Kaukinen K. Complete small intestine mucosal recovery is obtainable in the treatment of celiac disease [Letter]. Gastrointest Endosc. 2004;59:158-9. [PMID: 14740630]
19.
Hutchinson JMWest NPRobins GG, and Howdle PD. Long-term histological follow-up of people with coeliac disease in a UK teaching hospital. QJM. 2010;103:511-7. [PMID: 20519276]
20.
Kaukinen KPeräaho MLindfors KPartanen JWoolley NPikkarainen Pet al. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther. 2007;25:1237-45. [PMID: 17451570]
21.
Leffler D. Celiac disease diagnosis and management: a 46-year-old woman with anemia. JAMA. 2011;306:1582-92. [PMID: 21990301]
22.
Ludvigsson JFBrandt LMontgomery SMGranath F, and Ekbom A. Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterol. 2009;9:19. [PMID: 19284576]
23.
Ludvigsson JFMontgomery SMEkbom ABrandt L, and Granath F. Small-intestinal histopathology and mortality risk in celiac disease. JAMA. 2009;302:1171-8. [PMID: 19755695]
24.
Tuire IMarja-Leena LTeea SKatri HJukka PPäivi Set al. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease. Am J Gastroenterol. 2012;107:1563-9. [PMID: 22825364]
25.
Campo ESwerdlow SHHarris NLPileri SStein H, and Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117:5019-32. [PMID: 21300984]
26.
Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue'). Gastroenterology. 1992;102:330-54. [PMID: 1727768]
27.
Oberhuber GGranditsch G, and Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185-94. [PMID: 10524652]
28.
Logan RFRifkind EATurner ID, and Ferguson A. Mortality in celiac disease. Gastroenterology. 1989;97:265-71. [PMID: 2744350]
29.
Olén OAskling JLudvigsson JFHildebrand HEkbom A, and Smedby KE. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis. 2011;43:862-8. [PMID: 21880561]
30.
Leffler DADennis MEdwards George JBJamma SMagge SCook EFet al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol. 2009;7:530-6, 536.e1-2. [PMID: 19268725]
31.
Biagi FCampanella JMartucci SPezzimenti DCiclitira PJEllis HJet al. A milligram of gluten a day keeps the mucosal recovery away: a case report. Nutr Rev. 2004;62:360-3. [PMID: 15497770]
32.
Cellier CDelabesse EHelmer CPatey NMatuchansky CJabri Bet al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet. 2000;356:203-8. [PMID: 10963198]
33.
Sharaiha RZLebwohl BReimers LBhagat GGreen PH, and Neugut AI. Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008. Cancer. 2012;118:3786-92. [PMID: 22169928]

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 159Number 36 August 2013
Pages: 169 - 175

History

Published online: 6 August 2013
Published in issue: 6 August 2013

Keywords

Authors

Affiliations

Benjamin Lebwohl, MD, MS
From Columbia University College of Physicians and Surgeons, New York, New York; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; Mayo Clinic College of Medicine, Rochester, Minnesota; and Örebro University Hospital, Örebro, Sweden.
Fredrik Granath, PhD
From Columbia University College of Physicians and Surgeons, New York, New York; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; Mayo Clinic College of Medicine, Rochester, Minnesota; and Örebro University Hospital, Örebro, Sweden.
Anders Ekbom, MD, PhD
From Columbia University College of Physicians and Surgeons, New York, New York; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; Mayo Clinic College of Medicine, Rochester, Minnesota; and Örebro University Hospital, Örebro, Sweden.
Karin E. Smedby, MD, PhD
From Columbia University College of Physicians and Surgeons, New York, New York; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; Mayo Clinic College of Medicine, Rochester, Minnesota; and Örebro University Hospital, Örebro, Sweden.
Joseph A. Murray, MD
From Columbia University College of Physicians and Surgeons, New York, New York; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; Mayo Clinic College of Medicine, Rochester, Minnesota; and Örebro University Hospital, Örebro, Sweden.
Alfred I. Neugut, MD, PhD
From Columbia University College of Physicians and Surgeons, New York, New York; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; Mayo Clinic College of Medicine, Rochester, Minnesota; and Örebro University Hospital, Örebro, Sweden.
Peter H.R. Green, MD
From Columbia University College of Physicians and Surgeons, New York, New York; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; Mayo Clinic College of Medicine, Rochester, Minnesota; and Örebro University Hospital, Örebro, Sweden.
Jonas F. Ludvigsson, MD, PhD
From Columbia University College of Physicians and Surgeons, New York, New York; Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden; Mayo Clinic College of Medicine, Rochester, Minnesota; and Örebro University Hospital, Örebro, Sweden.
Grant Support: By The American-Scandinavian Foundation, Celiac Sprue Association, and grant KL2 TR000081 from the National Center for Advancing Translational Sciences of the National Institutes of Health (Dr. Lebwohl); Stockholm County Council (Dr. Ekbom); Strategic Research Program in Epidemiology's Young Scholar Award (Dr. Smedby); grants DK071003 and DK057892 from the National Institutes of Health (Dr. Murray); Örebro University Hospital, Karolinska Institutet, Swedish Society of Medicine, and grant 522-2A09-195 from the Swedish Research Council and the Swedish Celiac Society (Dr. Ludvigsson).
Reproducible Research Statement: Study protocol and statistical code: Available from Dr. Ludvigsson (e-mail, [email protected]). Data set: Not available.
Corresponding Author: Jonas F. Ludvigsson, MD, PhD, Department of Pediatrics, Örebro University Hospital, SE-70185 Örebro, Sweden; e-mail, [email protected].
Current Author Addresses: Drs. Lebwohl and Green: The Celiac Disease Center at Columbia University, 180 Fort Washington Avenue, Suite 936, New York, NY 10032.
Drs. Granath, Ekbom, and Smedby: Clinical Epidemiology Unit, Karolinska Institutet, Eugeniahemmet T2, SE-171 76, Stockholm, Sweden.
Dr. Murray: 200 First Street SW Mayo East 9, Rochester, MN 55905.
Dr. Neugut: Mailman School of Public Health, Columbia University, 722 West 168th Street, Room 725, New York, NY 10032.
Dr. Ludvigsson: Department of Pediatrics, Örebro University Hospital, SE-70185 Örebro, Sweden.
Author Contributions: Conception and design: B. Lebwohl, F. Granath, A. Ekbom, P.H.R. Green, J.F. Ludvigsson.
Analysis and interpretation of the data: B. Lebwohl, F. Granath, A. Ekbom, K.E. Smedby, J.A. Murray, A.I. Neugut, J.F. Ludvigsson.
Drafting of the article: B. Lebwohl, J.F. Ludvigsson.
Critical revision of the article for important intellectual content: B. Lebwohl, F. Granath, A. Ekbom, K.E. Smedby, J.A. Murray, A.I. Neugut, P.H.R. Green, J.F. Ludvigsson.
Final approval of the article: B. Lebwohl, F. Granath, A. Ekbom, K.E. Smedby, J.A. Murray, A.I. Neugut, P.H.R. Green, J.F. Ludvigsson.
Provision of study materials or patients: J.F. Ludvigsson.
Statistical expertise: B. Lebwohl, F. Granath, J.F. Ludvigsson.
Obtaining of funding: B. Lebwohl, A. Ekbom, J.F. Ludvigsson.
Administrative, technical, or logistic support: J.F. Ludvigsson.
Collection and assembly of data: J.F. Ludvigsson.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Benjamin Lebwohl, Fredrik Granath, Anders Ekbom, et al. Mucosal Healing and Risk for Lymphoproliferative Malignancy in Celiac Disease: A Population-Based Cohort Study. Ann Intern Med.2013;159:169-175. [Epub 6 August 2013]. doi:10.7326/0003-4819-159-3-201308060-00006

View More

Get Access

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/ePub

View PDF/ePub

Related in ACP Journals

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media